Dendreon Corporation has announced that it has completed its acquisition of Corvas International. The acquisition provides Dendreon with an enhanced product pipeline and the financial position to discover, develop and commercialize innovative therapeutic products in oncology. “This is a very exciting time for Dendreon, our stockholders and the many cancer patients who could potentially benefit Read more about Dendreon Corporation Completes Acquisition Of Corvas International[…]